FI20030015A0 - Menetelmä munuaisten vajaatoiminnan hoitamiseksi - Google Patents

Menetelmä munuaisten vajaatoiminnan hoitamiseksi

Info

Publication number
FI20030015A0
FI20030015A0 FI20030015A FI20030015A FI20030015A0 FI 20030015 A0 FI20030015 A0 FI 20030015A0 FI 20030015 A FI20030015 A FI 20030015A FI 20030015 A FI20030015 A FI 20030015A FI 20030015 A0 FI20030015 A0 FI 20030015A0
Authority
FI
Finland
Prior art keywords
renal failure
treating renal
treatment
failure
treating
Prior art date
Application number
FI20030015A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Matti Kivikko
Heimo Haikala
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Priority to FI20030015A priority Critical patent/FI20030015A0/fi
Publication of FI20030015A0 publication Critical patent/FI20030015A0/fi
Priority to DE602004005000T priority patent/DE602004005000T2/de
Priority to ES04700048T priority patent/ES2281775T3/es
Priority to AT04700048T priority patent/ATE355063T1/de
Priority to JP2006500147A priority patent/JP4588016B2/ja
Priority to US10/541,394 priority patent/US20060166994A1/en
Priority to PCT/FI2004/000002 priority patent/WO2004060375A1/fr
Priority to SI200430232T priority patent/SI1581227T1/sl
Priority to DK04700048T priority patent/DK1581227T3/da
Priority to EP04700048A priority patent/EP1581227B1/fr
Priority to PT04700048T priority patent/PT1581227E/pt
Priority to CA2511735A priority patent/CA2511735C/fr
Priority to CY20071100647T priority patent/CY1106586T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
FI20030015A 2003-01-03 2003-01-03 Menetelmä munuaisten vajaatoiminnan hoitamiseksi FI20030015A0 (fi)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FI20030015A FI20030015A0 (fi) 2003-01-03 2003-01-03 Menetelmä munuaisten vajaatoiminnan hoitamiseksi
CA2511735A CA2511735C (fr) 2003-01-03 2004-01-02 Traitement de l'insuffisance renale a l'aide de levosimendan, de son metabolite ou de ses sels
JP2006500147A JP4588016B2 (ja) 2003-01-03 2004-01-02 腎不全処置方法
ES04700048T ES2281775T3 (es) 2003-01-03 2004-01-02 Metodo para tratar insuficiencia renal.
AT04700048T ATE355063T1 (de) 2003-01-03 2004-01-02 Methode zur behandlung von niereninsuffizienz
DE602004005000T DE602004005000T2 (de) 2003-01-03 2004-01-02 Methode zur behandlung von niereninsuffizienz
US10/541,394 US20060166994A1 (en) 2003-01-03 2004-01-02 Method for treating renal failure
PCT/FI2004/000002 WO2004060375A1 (fr) 2003-01-03 2004-01-02 Procede pour traiter l'insuffisance renale
SI200430232T SI1581227T1 (sl) 2003-01-03 2004-01-02 Metoda za zdravljenje odpovedi ledvic
DK04700048T DK1581227T3 (da) 2003-01-03 2004-01-02 Fremgangsmåde til behandling af nyresvigt
EP04700048A EP1581227B1 (fr) 2003-01-03 2004-01-02 Procede pour traiter l'insuffisance renale
PT04700048T PT1581227E (pt) 2003-01-03 2004-01-02 Método para o tratamento de falha renal
CY20071100647T CY1106586T1 (el) 2003-01-03 2007-05-14 Μια μεθοδος για την θεραπευτικη αγωγη νεφρικης ανεπαρκειας

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20030015A FI20030015A0 (fi) 2003-01-03 2003-01-03 Menetelmä munuaisten vajaatoiminnan hoitamiseksi

Publications (1)

Publication Number Publication Date
FI20030015A0 true FI20030015A0 (fi) 2003-01-03

Family

ID=8565258

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20030015A FI20030015A0 (fi) 2003-01-03 2003-01-03 Menetelmä munuaisten vajaatoiminnan hoitamiseksi

Country Status (13)

Country Link
US (1) US20060166994A1 (fr)
EP (1) EP1581227B1 (fr)
JP (1) JP4588016B2 (fr)
AT (1) ATE355063T1 (fr)
CA (1) CA2511735C (fr)
CY (1) CY1106586T1 (fr)
DE (1) DE602004005000T2 (fr)
DK (1) DK1581227T3 (fr)
ES (1) ES2281775T3 (fr)
FI (1) FI20030015A0 (fr)
PT (1) PT1581227E (fr)
SI (1) SI1581227T1 (fr)
WO (1) WO2004060375A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007504136A (ja) 2003-08-28 2007-03-01 ニトロメッド インコーポレーティッド ニトロソ化およびニトロシル化利尿化合物、組成物、ならびに使用方法
FI20040674A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
EP1855688A4 (fr) 2005-02-24 2011-09-14 Nicox Sa Compositions et composes diuretiques renforçateurs d'oxyde nitrique, et leurs procedes d'utilisation
CA3145456A1 (fr) 2019-07-01 2021-01-07 Orion Corporation Procedes d'administration de(r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamide
JP2023507626A (ja) 2019-12-16 2023-02-24 テナックス・セラピューティクス，インコーポレイテッド 駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
JP3131845B2 (ja) * 1991-06-12 2001-02-05 帝国臓器製薬株式会社 慢性心不全治療剤
IL141120A0 (en) * 2000-01-31 2002-02-10 Pfizer Prod Inc Use of prostaglandin (pge2) receptor 4 (epa) selective agonists for the treatment of acute and chronic renal failure

Also Published As

Publication number Publication date
CA2511735A1 (fr) 2004-07-22
DE602004005000D1 (de) 2007-04-12
US20060166994A1 (en) 2006-07-27
SI1581227T1 (sl) 2007-06-30
PT1581227E (pt) 2007-03-30
ES2281775T3 (es) 2007-10-01
DK1581227T3 (da) 2007-04-23
ATE355063T1 (de) 2006-03-15
EP1581227B1 (fr) 2007-02-28
DE602004005000T2 (de) 2007-11-15
JP4588016B2 (ja) 2010-11-24
JP2006515348A (ja) 2006-05-25
CA2511735C (fr) 2011-09-20
WO2004060375A1 (fr) 2004-07-22
CY1106586T1 (el) 2012-01-25
EP1581227A1 (fr) 2005-10-05

Similar Documents

Publication Publication Date Title
ITMO20040191A1 (it) Macchina e metodo per il trattamento extracorporeo di sangue.
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
DK1638443T3 (da) Isoformer af hjerne-natriuretisk peptid
DE59911670D1 (de) Glutamin-Thiazolidide und -Pyrrolidide sowie ihre Verwendung als Dipeptidylpeptidase IV Inhibitoren
NO20053133D0 (no) Kjemiske forbindelser.
NO20040518L (no) Filtre for kansellering av flere stoykilder i et elektromagnetisk telemetrisystem for et borehull.
NO20032848L (no) Substituerte triazoldiaminderivater som kinaseinhibitorer
BR0116519A (pt) Cartucho de hemodiafiltração/hemofiltração de diluição intermediária e método de hemodiafiltração/hemofiltração em um cartucho único
WO2006055981A3 (fr) Compositions et methodes de traitement de l'insuffisance cardiaque congestive
TW200616639A (en) Methods for treating a mammal before, during and after cardiac arrest
TR200401028T2 (tr) Kistik fibrozun tedavisine yönelik metot
NL1021504A1 (nl) Waterstofbehandelingsproces.
BR0200467B1 (pt) mÉtodo de tratamento quÍmico de fosfato eletrolÍtico.
DE60328603D1 (de) Prodrugs von imidazol-derivaten, zur verwendung als protonenpumpen-hemmer zur behandlung von z.b. peptischen magengeschwüren
FI20030015A0 (fi) Menetelmä munuaisten vajaatoiminnan hoitamiseksi
ITVR20020088A1 (it) Macchina flessografica.
TW200618799A (en) Method for manufacturing imidazole compounds and salts and pseudopolymorphs thereof
IS7705A (is) 4-(3,5-Dísýanófenoxý) pýrasól afleiður til notkunar sem bakritunarstillar við meðhöndlun á m.a. eyðniveirunni
NO20024439D0 (no) Polymert, akrylamidfritt middel for tilbakeholdelse av vann
DK1368023T3 (da) Anvendelse af buprenoprphin til behandling af urininkontinens
TW200635584A (en) Use of PPAR agonists for the treatment of congestive heart failure
NO20024545L (no) Fremgangsmåte for behandling av kongestiv hjertefeil
NO20065545L (no) Fremgangsmate for en enzymatisk oksygenering ved direkte elektokjemisk regenerering av FAD-avhengig monooksygenase
DE60226126D1 (de) Verwendung von gamma-gt inhibitoren zur behandlung von chronischen degenerativerkrankungen
ITRM20020308A0 (it) Apparecchiatura per trattamenti terapeutici, e relativo metodo.